CTIC Annual CFF
$120.02 M
+$22.08 M+22.54%
31 December 2022
Summary:
As of February 5, 2025, CTIC annual cash flow from financing activities is $120.02 million, with the most recent change of +$22.08 million (+22.54%) on December 31, 2022. During the last 3 years, it has risen by +$125.63 million (+2240.56%).CTIC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Quarterly CFF
$9.63 M
-$3.71 M-27.82%
31 March 2023
Summary:
As of February 5, 2025, CTIC quarterly cash flow from financing activities is $9.63 million, with the most recent change of -$3.71 million (-27.82%) on March 31, 2023. Over the past year, it has dropped by -$51.80 million (-84.32%).CTIC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC TTM CFF
$68.22 M
-$51.80 M-43.16%
31 March 2023
Summary:
As of February 5, 2025, CTIC TTM cash flow from financing activities is $68.22 million, with the most recent change of -$51.80 million (-43.16%) on March 31, 2023. Over the past year, it has dropped by -$89.67 million (-56.79%).CTIC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +22.5% | -84.3% | -56.8% |
3 y3 years | +2240.6% | -83.4% | +27.0% |
5 y5 years | +207.9% | -85.1% | +1316.7% |
CTIC Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -29.2% | -93.3% | -75.3% |
CTI BioPharma Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2023 | - | $9.63 M(-27.8%) | $68.22 M(-43.2%) |
Dec 2022 | $120.02 M(+22.5%) | $13.35 M(+1205.8%) | $120.02 M(+12.3%) |
Sept 2022 | - | $1.02 M(-97.7%) | $106.86 M(-28.6%) |
June 2022 | - | $44.22 M(-28.0%) | $149.74 M(-5.2%) |
Mar 2022 | - | $61.43 M(>+9900.0%) | $157.89 M(+61.2%) |
Dec 2021 | $97.94 M(+60.4%) | $188.00 K(-99.6%) | $97.94 M(-5.5%) |
Sept 2021 | - | $43.90 M(-16.2%) | $103.68 M(+77.4%) |
June 2021 | - | $52.37 M(+3419.4%) | $58.45 M(+1167.2%) |
Mar 2021 | - | $1.49 M(-74.9%) | $4.61 M(-92.4%) |
Dec 2020 | $61.07 M(-1189.2%) | $5.93 M(-544.9%) | $61.07 M(+14.0%) |
Sept 2020 | - | -$1.33 M(-9.4%) | $53.58 M(0.0%) |
June 2020 | - | -$1.47 M(-102.5%) | $53.58 M(-0.3%) |
Mar 2020 | - | $57.95 M(-3807.4%) | $53.72 M(-1058.1%) |
Dec 2019 | -$5.61 M(-108.8%) | -$1.56 M(+17.3%) | -$5.61 M(+20.4%) |
Sept 2019 | - | -$1.33 M(0.0%) | -$4.66 M(+40.5%) |
June 2019 | - | -$1.33 M(-3.3%) | -$3.31 M(+34.1%) |
Mar 2019 | - | -$1.38 M(+125.2%) | -$2.47 M(-103.9%) |
Dec 2018 | $63.49 M(+62.9%) | -$612.00 K(-6900.0%) | $63.49 M(-2.5%) |
Sept 2018 | - | $9000.00(-101.8%) | $65.09 M(+1.7%) |
June 2018 | - | -$491.00 K(-100.8%) | $64.03 M(-39.3%) |
Mar 2018 | - | $64.58 M(+6450.2%) | $105.54 M(+170.8%) |
Dec 2017 | $38.98 M(-629.2%) | $986.00 K(-193.9%) | $38.98 M(+12.0%) |
Sept 2017 | - | -$1.05 M(-102.6%) | $34.81 M(+2.3%) |
June 2017 | - | $41.02 M(-2179.9%) | $34.04 M(-474.5%) |
Mar 2017 | - | -$1.97 M(-38.1%) | -$9.09 M(+23.4%) |
Dec 2016 | -$7.37 M(-104.8%) | -$3.18 M(+74.9%) | -$7.37 M(-107.4%) |
Sept 2016 | - | -$1.82 M(-13.9%) | $99.65 M(-14.9%) |
June 2016 | - | -$2.11 M(+748.6%) | $117.15 M(-24.3%) |
Mar 2016 | - | -$249.00 K(-100.2%) | $154.81 M(+1.8%) |
Dec 2015 | $152.02 M(+322.0%) | $103.83 M(+562.0%) | $152.02 M(+80.1%) |
Sept 2015 | - | $15.69 M(-55.9%) | $84.39 M(+22.9%) |
June 2015 | - | $35.54 M(-1270.2%) | $68.65 M(+106.8%) |
Mar 2015 | - | -$3.04 M(-108.4%) | $33.20 M(-7.9%) |
Dec 2014 | $36.03 M(-38.9%) | $36.20 M(<-9900.0%) | $36.03 M(+4.1%) |
Sept 2014 | - | -$57.00 K(-167.9%) | $34.62 M(-29.9%) |
June 2014 | - | $84.00 K(-140.8%) | $49.40 M(+0.6%) |
Mar 2014 | - | -$206.00 K(-100.6%) | $49.13 M(-16.7%) |
Dec 2013 | $58.97 M(-32.4%) | $34.80 M(+136.3%) | $58.97 M(-25.1%) |
Sept 2013 | - | $14.72 M(-7973.8%) | $78.78 M(+1.0%) |
June 2013 | - | -$187.00 K(-101.9%) | $77.99 M(-19.6%) |
Mar 2013 | - | $9.64 M(-82.4%) | $96.94 M(+11.2%) |
Dec 2012 | $87.22 M(+0.2%) | $54.61 M(+292.1%) | $87.22 M(+116.0%) |
Sept 2012 | - | $13.93 M(-25.8%) | $40.37 M(-16.8%) |
June 2012 | - | $18.77 M(<-9900.0%) | $48.55 M(+21.3%) |
Mar 2012 | - | -$87.00 K(-101.1%) | $40.03 M(-54.0%) |
Dec 2011 | $87.00 M(+75.0%) | $7.76 M(-64.9%) | $87.00 M(-11.5%) |
Sept 2011 | - | $22.11 M(+115.7%) | $98.34 M(+139.0%) |
June 2011 | - | $10.25 M(-78.1%) | $41.15 M(-40.4%) |
Mar 2011 | - | $46.88 M(+145.4%) | $69.09 M(+39.0%) |
Dec 2010 | $49.72 M(-47.5%) | $19.11 M(-154.4%) | $49.72 M(+59.4%) |
Sept 2010 | - | -$35.09 M(-191.9%) | $31.19 M(-76.0%) |
June 2010 | - | $38.19 M(+38.8%) | $129.78 M(+3.4%) |
Mar 2010 | - | $27.52 M(+4701.9%) | $125.50 M(+32.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | $94.78 M(+28.6%) | $573.00 K(-99.1%) | $94.78 M(-11.2%) |
Sept 2009 | - | $63.49 M(+87.2%) | $106.78 M(+68.0%) |
June 2009 | - | $33.91 M(-1157.2%) | $63.56 M(+24.4%) |
Mar 2009 | - | -$3.21 M(-125.5%) | $51.11 M(-30.7%) |
Dec 2008 | $73.73 M(-13.0%) | $12.58 M(-37.9%) | $73.73 M(+0.0%) |
Sept 2008 | - | $20.27 M(-5.6%) | $73.70 M(+2.2%) |
June 2008 | - | $21.47 M(+10.6%) | $72.14 M(-15.5%) |
Mar 2008 | - | $19.41 M(+54.6%) | $85.39 M(+0.8%) |
Dec 2007 | $84.70 M(-17.6%) | $12.55 M(-32.9%) | $84.70 M(+1.0%) |
Sept 2007 | - | $18.71 M(-46.1%) | $83.85 M(-18.6%) |
June 2007 | - | $34.72 M(+85.5%) | $102.98 M(+0.3%) |
Mar 2007 | - | $18.72 M(+59.9%) | $102.67 M(-0.1%) |
Dec 2006 | $102.74 M(+745.6%) | $11.71 M(-69.1%) | $102.74 M(-28.4%) |
Sept 2006 | - | $37.84 M(+10.0%) | $143.43 M(+117.7%) |
June 2006 | - | $34.41 M(+83.1%) | $65.87 M(+111.3%) |
Mar 2006 | - | $18.79 M(-64.1%) | $31.17 M(+156.6%) |
Dec 2005 | $12.15 M(-86.3%) | $52.39 M(-231.9%) | $12.15 M(+256.9%) |
Sept 2005 | - | -$39.72 M(>+9900.0%) | $3.40 M(-96.2%) |
June 2005 | - | -$294.00 K(+26.2%) | $88.47 M(-0.3%) |
Mar 2005 | - | -$233.00 K(-100.5%) | $88.78 M(-0.1%) |
Dec 2004 | $88.89 M(+22.3%) | $43.65 M(-3.8%) | $88.89 M(+96.6%) |
Sept 2004 | - | $45.35 M(>+9900.0%) | $45.22 M(>+9900.0%) |
June 2004 | - | $7000.00(-106.1%) | $248.00 K(-99.7%) |
Mar 2004 | - | -$115.00 K(+310.7%) | $72.78 M(+0.1%) |
Dec 2003 | $72.70 M(-684.0%) | -$28.00 K(-107.3%) | $72.70 M(-3.6%) |
Sept 2003 | - | $384.00 K(-99.5%) | $75.45 M(+4.7%) |
June 2003 | - | $72.54 M(<-9900.0%) | $72.06 M(-669.1%) |
Mar 2003 | - | -$191.00 K(-107.0%) | -$12.66 M(+1.7%) |
Dec 2002 | -$12.45 M(-107.3%) | $2.72 M(-190.4%) | -$12.45 M(-7.4%) |
Sept 2002 | - | -$3.01 M(-75.3%) | -$13.45 M(-202.2%) |
June 2002 | - | -$12.18 M(<-9900.0%) | $13.16 M(-92.2%) |
Mar 2002 | - | $20.00 K(-98.8%) | $169.47 M(-0.1%) |
Dec 2001 | $169.57 M(+0.9%) | $1.72 M(-92.7%) | $169.57 M(-0.8%) |
Sept 2001 | - | $23.60 M(-83.6%) | $170.88 M(-38.1%) |
June 2001 | - | $144.13 M(>+9900.0%) | $276.04 M(+112.7%) |
Mar 2001 | - | $121.10 K(-96.0%) | $129.77 M(-22.7%) |
Dec 2000 | $167.97 M(+1899.7%) | $3.03 M(-97.6%) | $167.97 M(-3.5%) |
Sept 2000 | - | $128.75 M(-6134.0%) | $174.14 M(+286.2%) |
June 2000 | - | -$2.13 M(-105.6%) | $45.09 M(-4.1%) |
Mar 2000 | - | $38.32 M(+316.5%) | $47.02 M(+459.8%) |
Dec 1999 | $8.40 M(+600.0%) | $9.20 M(-3166.7%) | $8.40 M(-1033.3%) |
Sept 1999 | - | -$300.00 K(+50.0%) | -$900.00 K(-169.2%) |
June 1999 | - | -$200.00 K(-33.3%) | $1.30 M(+8.3%) |
Mar 1999 | - | -$300.00 K(+200.0%) | $1.20 M(0.0%) |
Dec 1998 | $1.20 M(-98.2%) | -$100.00 K(-105.3%) | $1.20 M(-96.8%) |
Sept 1998 | - | $1.90 M(-733.3%) | $37.10 M(+5.1%) |
June 1998 | - | -$300.00 K(0.0%) | $35.30 M(0.0%) |
Mar 1998 | - | -$300.00 K(-100.8%) | $35.30 M(-45.8%) |
Dec 1997 | $65.10 M(+201.4%) | $35.80 M(>+9900.0%) | $65.10 M(+122.2%) |
Sept 1997 | - | $100.00 K(-133.3%) | $29.30 M(+0.3%) |
June 1997 | - | -$300.00 K(-101.0%) | $29.20 M(-1.0%) |
Mar 1997 | - | $29.50 M | $29.50 M |
Dec 1996 | $21.60 M | - | - |
FAQ
- What is CTI BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for CTI BioPharma?
- What is CTI BioPharma annual CFF year-on-year change?
- What is CTI BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CTI BioPharma?
- What is CTI BioPharma quarterly CFF year-on-year change?
- What is CTI BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for CTI BioPharma?
- What is CTI BioPharma TTM CFF year-on-year change?
What is CTI BioPharma annual cash flow from financing activities?
The current annual CFF of CTIC is $120.02 M
What is the all time high annual CFF for CTI BioPharma?
CTI BioPharma all-time high annual cash flow from financing activities is $169.57 M
What is CTI BioPharma annual CFF year-on-year change?
Over the past year, CTIC annual cash flow from financing activities has changed by +$22.08 M (+22.54%)
What is CTI BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of CTIC is $9.63 M
What is the all time high quarterly CFF for CTI BioPharma?
CTI BioPharma all-time high quarterly cash flow from financing activities is $144.13 M
What is CTI BioPharma quarterly CFF year-on-year change?
Over the past year, CTIC quarterly cash flow from financing activities has changed by -$51.80 M (-84.32%)
What is CTI BioPharma TTM cash flow from financing activities?
The current TTM CFF of CTIC is $68.22 M
What is the all time high TTM CFF for CTI BioPharma?
CTI BioPharma all-time high TTM cash flow from financing activities is $276.04 M
What is CTI BioPharma TTM CFF year-on-year change?
Over the past year, CTIC TTM cash flow from financing activities has changed by -$89.67 M (-56.79%)